Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.765%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

22 Jan 2019 07:00

RNS Number : 6986N
Mortgage Advice Bureau(Holdings)PLC
22 January 2019
 

22 January 2019

Mortgage Advice Bureau (Holdings) plc ("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1), one of the UK's leading consumer intermediary brands and specialist Appointed Representative Networks, today issues a trading update for the year ended 31 December 2018, ahead of publishing its final results announcement on Tuesday, 19 March 2019(1).

Revenue for the year ended 31 December 2018 increased by 13% to £123m driven by a 12% increase in the average number of Advisers to 1,130 in the year ended 31 December 2018 (2017: 1,008). The total number of Advisers had increased to 1,213 at 31 December 2018, an increase of 135 or 13% since last year end (2017: 1,078). For 2018 as a whole, we saw an increase in average revenue per adviser of 1%, continuing our growth in productivity despite the ongoing economic uncertainty driven by the Brexit agenda and a reduction in housing transactions overall.

The Group's profit before tax for the year ended 31 December 2018 is broadly in line with the Board's expectations. At 31 December 2018, the Group had a strong balance sheet with a cash position of over £25m, including over £13m of unrestricted cash balances. 

Although UK Finance has not recently updated its estimates for gross new mortgage lending for 2018 and 2019, the current information and run rates broadly support their previous estimates of £260bn and £271bn for 2018 and 2019 respectively, indicating that the market is likely to be relatively flat in the near term. These figures exclude Product Transfers, and it has only been over the last year or so that the large lenders have engaged intermediaries to help them to retain their existing mortgage borrowers through product transfers, with intermediaries continuing to grow their share of this market. UK Finance has recently revised its original estimates for the size of the product transfer market, indicating an annual market size of c. £140bn.

(1) It is expected that a proposed final dividend in respect of the year ended 31 December 2018 will be paid on 24 May 2019 to shareholders on the register at close of business on 26 April 2019.

Peter Brodnicki, CEO of Mortgage Advice Bureau (Holdings) plc, said:

"MAB has delivered another strong performance despite the uncertainty caused by the ongoing Brexit negotiations. We continue to grow our market share and invest in accordance with our very clear strategy to ensure continued and sustainable growth.

 "We are looking forward to capitalising upon our recent protection initiatives to increase performance whilst also delivering the initial phase of our next generation MIDAS technology in the first half of this year. Both of these initiatives are already proving to be important recruitment drivers for Appointed Representatives, advisers and lead sources. This initial phase and further releases across 2019 and 2020 will benefit MAB advisers and customers, through improvements in efficiency, productivity, lead generation, product offering and customer experience. We are excited about how delivering this will help us to attract more advisers and customers into MAB, assisting our future growth plans."

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Managing Director

David Preece, Chief Operating Officer

Lucy Tilley, Finance Director

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Jamie Lillywhite (Corporate Finance)

Michael Burke (Corporate Broking)

 

Media Enquiries:

 

investorrelations@mab.org.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEEESFFUSELF
Date   Source Headline
13th Jun 20234:39 pmRNSTR-1: Notification of major holdings
1st Jun 202311:52 amRNSDirector/PDMR Shareholding
24th May 20235:16 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
16th May 20232:23 pmRNSPDMR Dealing and Total Voting Rights
28th Apr 20231:53 pmRNSDirectors' Shareholdings and PDMR notification
27th Apr 20234:39 pmRNSNotification of major holdings
20th Apr 20234:29 pmRNSPosting of Report and Accounts and Notice of AGM
17th Apr 20235:08 pmRNSPDMR dealing and Total Voting Rights
31st Mar 20232:25 pmRNSDirectors' Shareholdings and PDMR notification
28th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
14th Mar 20235:05 pmRNSDirectors' Shareholdings and PDMR notification
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:35 pmRNSNon-Executive Director Board change
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20231:54 pmRNSDirectors' Shareholdings and PDMR notification
24th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20235:06 pmRNSDirectors' Shareholdings and PDMR notification
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
31st Jan 20237:00 amRNSTrading Update
17th Jan 20234:07 pmRNSDirectors' Shareholdings and PDMR notification
3rd Jan 20239:54 amRNSDirector's Shareholdings and PDMR notification
21st Dec 20227:00 amRNSAppointment of Joint Broker
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20221:51 pmRNSDirectors' Shareholdings and PDMR notification
1st Dec 20227:00 amRNSTrading Update
30th Nov 20224:50 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20224:15 pmRNSPDMR dealing notification and Total Voting Rights
7th Nov 20225:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Oct 20221:18 pmRNSDirectors' Shareholdings and PDMR notification
14th Oct 20225:04 pmRNSDirectors' Shareholdings and PDMR notification
6th Oct 20225:16 pmRNSHolding(s) in Company
6th Oct 20227:00 amRNSDirectors' Shareholdings and PDMR notification
4th Oct 20224:27 pmRNSHolding(s) in Company
3rd Oct 20225:13 pmRNSTotal Voting Rights
3rd Oct 20225:11 pmRNSHolding(s) in Company
30th Sep 202210:21 amRNSDirectors' Shareholdings and PDMR notification
27th Sep 20227:00 amRNSInterim Results
16th Sep 202210:36 amRNSDirectors' Shareholdings and PDMR notification
31st Aug 202212:53 pmRNSDirectors' Shareholdings and PDMR notification
16th Aug 202210:27 amRNSDirector/PDMR Shareholding
8th Aug 20224:36 pmRNSDirectors' Shareholdings and PDMR notification
29th Jul 20221:03 pmRNSPDMR dealing notification and Total Voting Rights
28th Jul 20224:40 pmRNSSecond Price Monitoring Extn
28th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSTrading Update
14th Jul 20225:31 pmRNSDirector/PDMR Shareholding
14th Jul 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.